Pathway 2

Pathway 2™

Supports cell clearing, proliferation, and cell-cycle modulation.

ONCO-ADJUNCT™ Pathway 2™ delivers two LPS™ bioactive polyphenols using brown rice protein as the protein scaffold, with the addition of frankincense.

• UltraCür™ LPS™ Brown Rice-Curcumin supports cell clearing by activating the p53, NRF2, and NFkB pathways.
• UltraCür® LPS™ Brown Rice-Quercetin also supports the p53 pathway, and additionally activates TLR4 and histamine related pathways in the body, supporting cell proliferation and cell-cycle modulation.*
• Frankincense (Boswellia) supports cell proliferation and synergizes the activity of our LPS™ ingredients.*

Why You’ll Love Our New/Improved Pathway 2™

Three reasons you’ll love the new, improved formula:

1. Our new formula uses brown rice protein conjugate, which reduces cysteine but still contains the same amounts of curcumin, quercetin, and Boswellia as our original formula.
2. Capsules can be opened and used in powder form for drinking or smoothies, if desired.
3. Capsule size is the same, but bottles now contain 180 capsules instead of 60. Dosage is 3 capsules twice per day, so each bottle is still a 1-month supply.

Taken together with Pathway 1™, Pathway 3™, and Pathway 4™, Pathway 2™ helps modulate the function of your cellular pathways to promote cellular activity.

IMPORTANT WARNING:

This product should only be used under medical supervision. Do not use without consulting your doctor if you are taking any blood thinners.

We advise you to consult with your healthcare practitioners regarding any questions or concerns about using these products, and their appropriate dosing.

Do not take this product on the day before, day of, or day after a chemotherapy treatment, as it may diminish the effectiveness of chemo cytotoxic interventions.

The following interactions with curcumin have been discussed in the medical literature:

Chemo therapeutic suppression was potentially found with curcumin and camptothecin, mechlorethamine, and doxorubicin. Somasundaram S, Edmund NA, Moore DT, Small GW, Shi YY, Orlowski RZ. Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res. 2002;62(13):3868-3875. (PubMed)

Curcumin affects the FXa node in the thrombin pathway. Any anti-coagulant therapy that acts directly on thrombin should be avoided (Hirudin, Argatroban, Bivalirudin, Dabigatran). Any Indirect or direct FXa inhibitors should be discussed with your doctor.